GlassScriptPhysician profile
Val Vogt
NPI 1801811237
$5,981.76
in general payments reported to CMS, 2019-2025
29 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $586 · 2021: $2,508 · 2022: $553 · 2023: $881 · 2024: $486 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,505.62 | 2020-2024 | Axonics, Bulkamid |
| Amgen INC. | $953.67 | 2019-2023 | Prolia |
| Sumitomo Pharma America, INC. | $675.16 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $673.42 | 2019-2024 | Myrbetriq |
| Abbvie INC. | $272.34 | 2022-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $189.90 | 2021-2023 | Provenge |
| Urogen Pharma, INC. | $185.03 | 2020-2024 | Jelmyto |
| Myovant Sciences INC. | $170.34 | 2021-2022 | |
| Allergan, INC. | $156.36 | 2019-2021 | |
| Procept Biorobotics Corporation | $139.61 | 2021-2024 | Aquabeam System |
| Boston Scientific Corporation | $131.92 | 2021-2022 | |
| Clarus Therapeutics INC. | $103.09 | 2020 | |
| Coloplast Corp | $97.27 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $96.88 | 2022-2024 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $96.29 | 2021-2024 | Erleada |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $91.97 | 2022-2024 | Trelstar, Tlando |
| Blue Earth Diagnostics | $80.39 | 2021-2024 | |
| Myriad Genetic Laboratories, INC. | $64.17 | 2023-2024 | Prolaris |
| Laborie Medical Technologies Corp. | $52.20 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Telix Pharmaceuticals | $48.42 | 2024-2025 | Illuccix |
| Urovant Sciences INC | $44.28 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $34.59 | 2025 | |
| Conmed Corporation | $25.25 | 2024 | Airseal |
| Travere Therapeutics, INC. | $21.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $21.23 | 2020 | |
| Sun Pharmaceutical Industries INC. | $14.43 | 2023 | Yonsa |
| Sandoz INC. | $14.33 | 2025 | Wyost, Jubbonti |
| Caldera Medical, INC | $12.00 | 2022 | |
| Valencia Technologies Corporation | $9.89 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Val Vogt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.